These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 15520830

  • 21. Deletion/insertion polymorphism in the angiotension-converting enzyme gene as a risk factor in the Slovenian patients with coronary heart disease.
    Peterlin B, Petrovic D, Zorc M, Keber I.
    Pflugers Arch; 2000; 439(3 Suppl):R40-1. PubMed ID: 10653136
    [Abstract] [Full Text] [Related]

  • 22. Influence of the ACE gene insertion/deletion polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects.
    Bonnet F, Patel S, Laville M, Balkau B, Favuzzi A, Monti LD, Lalic N, Walker M, European Group for the Study of Insulin Resistance Relationship Between Insulin Sensitivity and Cardiovascular Disease Risk Study Group.
    Diabetes Care; 2008 Apr; 31(4):789-94. PubMed ID: 18235053
    [Abstract] [Full Text] [Related]

  • 23. Influence of angiotensin-converting enzyme gene insertion/deletion polymorphism on rheumatic valve involvement, valve severity and subsequent valve calcification.
    Davutoglu V, Nacak M.
    J Heart Valve Dis; 2005 May; 14(3):277-81. PubMed ID: 15974518
    [Abstract] [Full Text] [Related]

  • 24. Insertion/deletion polymorphism of angiotensin I converting enzyme gene and left ventricular hypertrophy in patients with type 2 diabetes mellitus.
    Moleda P, Majkowska L, Kaliszczak R, Safranow K, Adler G, Goracy I.
    Kardiol Pol; 2006 Sep; 64(9):959-65; discussion 966. PubMed ID: 17054027
    [Abstract] [Full Text] [Related]

  • 25. Angiotensin-converting enzyme insertion/deletion gene polymorphism in inflammatory bowel diseases.
    Saibeni S, Spina L, Virgilio T, Folcioni A, Borsi G, de Franchis R, Cugno M, Vecchi M.
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):976-81. PubMed ID: 18049167
    [Abstract] [Full Text] [Related]

  • 26. A Val227Ala substitution in the peroxisome proliferator activated receptor alpha (PPAR alpha) gene associated with non-alcoholic fatty liver disease and decreased waist circumference and waist-to-hip ratio.
    Chen S, Li Y, Li S, Yu C.
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1415-8. PubMed ID: 18853997
    [Abstract] [Full Text] [Related]

  • 27. Angiotensin converting enzyme gene polymorphism in Turkish asthmatic patients.
    Eryüksel E, Ceyhan BB, Bircan R, Avşar M, Cirakoğlu B.
    J Asthma; 2009 May; 46(4):335-8. PubMed ID: 19484664
    [Abstract] [Full Text] [Related]

  • 28. Association of angiotensin-converting enzyme (ACE) gene insertion-deletion polymorphism with spondylarthropathies.
    Shehab DK, Al-Jarallah KF, Al-Awadhi AM, Al-Herz A, Nahar I, Haider MZ.
    J Biomed Sci; 2008 Jan; 15(1):61-7. PubMed ID: 17713861
    [Abstract] [Full Text] [Related]

  • 29. Angiotensin converting enzyme insertion/deletion polymorphism is associated with increased adiposity and blood pressure in obese children and adolescents.
    Lemes VA, Neves AL, Guazzelli IC, Frazzatto E, Nicolau C, Corrêa-Giannella ML, Velho G, Villares SM.
    Gene; 2013 Dec 15; 532(2):197-202. PubMed ID: 24076353
    [Abstract] [Full Text] [Related]

  • 30. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR, Kong NC, Gafor AH, Rahman AF, Zainuddin S, Mustaffa WM, Radzi AM, Shamsul AS.
    Singapore Med J; 2008 Nov 15; 49(11):924-9. PubMed ID: 19037561
    [Abstract] [Full Text] [Related]

  • 31. Interaction between the angiotensin-converting enzyme gene insertion/deletion polymorphism and obstructive sleep apnoea as a mechanism for hypertension.
    Boström KB, Hedner J, Melander O, Grote L, Gullberg B, Råstam L, Groop L, Lindblad U.
    J Hypertens; 2007 Apr 15; 25(4):779-83. PubMed ID: 17351369
    [Abstract] [Full Text] [Related]

  • 32. Abdominal obesity and the spectrum of global cardiometabolic risks in US adults.
    Ghandehari H, Le V, Kamal-Bahl S, Bassin SL, Wong ND.
    Int J Obes (Lond); 2009 Feb 15; 33(2):239-48. PubMed ID: 19050677
    [Abstract] [Full Text] [Related]

  • 33. Lack of association between the angiotensin-converting enzyme gene (I/D) polymorphism and diabetic nephropathy in Tunisian type 2 diabetic patients.
    Arfa I, Abid A, Nouira S, Elloumi-Zghal H, Malouche D, Mannai I, Zorgati MM, Ben Alaya N, Rebai A, Zouari B, Ben Ammar S, Ben Rayana MC, Hmida S, Blousa-Chabchoub S, Abdelhak S.
    J Renin Angiotensin Aldosterone Syst; 2008 Mar 15; 9(1):32-6. PubMed ID: 18404607
    [Abstract] [Full Text] [Related]

  • 34. Relationships between blood pressure, polymorphism of angiotensin-converting enzyme (ACE), body composition and biochemical characteristics in elderly Slovaks.
    Siváková D, Lajdová A, Basistová Z, Cvícelová M, Karabová P, Blazícek P.
    Anthropol Anz; 2008 Jun 15; 66(2):199-209. PubMed ID: 18712159
    [Abstract] [Full Text] [Related]

  • 35. Angiotensin-converting enzyme insertion/deletion polymorphism and retinal artery occlusion.
    Schäfer E, Weger M, Birgül T, Renner W, Stanger O, Steinbrugger I, Schmut O, Temmel W, Haas A.
    Acta Ophthalmol Scand; 2006 Jun 15; 84(3):305-8. PubMed ID: 16704688
    [Abstract] [Full Text] [Related]

  • 36. Angiotensin-converting enzyme gene polymorphism and stroke in type 2 diabetic patients in Taiwan.
    Tseng CH, Tseng CP, Chong CK, Sheu JJ, Cheng JC.
    Eur J Clin Invest; 2007 Jun 15; 37(6):483-91. PubMed ID: 17537156
    [Abstract] [Full Text] [Related]

  • 37. Angiotensin I-converting enzyme gene polymorphism modifies the smoking-cancer association: the Hisayama Study.
    Arima H, Kiyohara Y, Tanizaki Y, Nakabeppu Y, Kubo M, Kato I, Sueishi K, Tsuneyoshi M, Fujishima M, Iida M.
    Eur J Cancer Prev; 2006 Jun 15; 15(3):196-201. PubMed ID: 16679861
    [Abstract] [Full Text] [Related]

  • 38. Association between the ACE genotype and coronary artery disease. Insights from studies on restenosis, vasomotion and thrombosis.
    Bauters C, Amouyel P.
    Eur Heart J; 1998 Sep 15; 19 Suppl J():J24-9. PubMed ID: 9796837
    [Abstract] [Full Text] [Related]

  • 39. Beta(2)-adrenergic receptor mutation and abdominal obesity risk: effect modification by gender and HDL-cholesterol.
    Corbalán MS, Marti A, Forga L, Martínez-González MA, Martínez JA.
    Eur J Nutr; 2002 Jun 15; 41(3):114-8. PubMed ID: 12111048
    [Abstract] [Full Text] [Related]

  • 40. Genetic variation in the renin-angiotensin system and abdominal adiposity in men: the Olivetti Prospective Heart Study.
    Strazzullo P, Iacone R, Iacoviello L, Russo O, Barba G, Russo P, D'Orazio A, Barbato A, Cappuccio FP, Farinaro E, Siani A, Olivetti Prospective Heart Study.
    Ann Intern Med; 2003 Jan 07; 138(1):17-23. PubMed ID: 12513040
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.